Andrea Wainer is executive vice president of rapid and molecular diagnostics at Abbott. In this position since 2019, she leads two of the company’s businesses that have made a significant contribution to the global battle against COVID-19. She also oversees businesses providing a handheld point-of-care device and an informatics solution provider.

Wainer joined Abbott in 1997 and served in a variety of roles within the pharmaceuticals business. Later, she led Abbott’s animal health business prior to its acquisition by Zoetis in 2015. Also in her career, Wainer has been senior director of urology marketing at Astellas and a marketing team leader at Pfizer.

COVID-19, Virus, Vaccines, Health, Healthcare, Business of Healthcare, Healthcare Quality & Safety, Healthcare Providers, Female Leadership, Empowerment, Influential Women, Aspen Ideas, Aspen Health